Wearable AI coach
Apple Health+ / Apple health coach (Project Mulberry)
Apple Health+ / Project Mulberry remains an unscored watch-list concept in this review. No official named deployment was verified. Controls from the existing Apple Health app cannot be assumed to apply to this proposed coach.
Checklist assessment dated October 30, 2026. Independent confirmation is incomplete. Hugo has not personally verified this service.
Agency checklist
Not assessed
Not deployed in the assessed directory scope.
This is not a zero score or an adverse agency finding.
Earlier v1.3 assessment and control finding
Historical assessment under different rules. It does not set the current checklist zone.
Agency finding, before method v1.3
Unclear, named deployment unverified
Legacy editorial placement, pre-method: 70
This profile has not yet been reviewed under the published method. Its finding and any number are editorial placements made before the method existed.
- Evidence
- Documentary review. Public sources only, no hands-on testing by HugoScore.
- Review status
- AI draft. No person has settled the findings.
Earlier evidence and assessment
The sections below preserve the earlier review. Its classifications and provenance are historical; the checklist above gives the current draft classification.
Earlier finding · Legacy editorial placement, pre-method: 70
Method v1.3. The control line is evidence for how the agency finding arose, not a quality score. Legacy editorial placement, pre-method: 70. Not comparable with v1.3 positions.
Unclear, named deployment unverified
Apple Health+ / Project Mulberry remains an unscored watch-list concept in this review. No official named deployment was verified. Controls from the existing Apple Health app cannot be assumed to apply to this proposed coach.
Patient agency
How this tool changes agency
The reported ability to interpret personal health information is only design intent. No reviewed coach interaction establishes source checking or support for challenging care decisions.
Existence, availability and all product-specific control arrangements remain unresolved
Patient agency assessment
Who sets and changes the goal?
No product-specific authority, redirection or output controls were established. Existing Apple Health controls cannot be transferred to the reported concept.
What can the patient understand, question, or do?
The reported ability to interpret personal health information is only design intent. No reviewed coach interaction establishes source checking or support for challenging care decisions.
Can the patient evaluate the conditions of use?
Subscription, cloud processing and privacy claims for this concept remain unverified. Do not borrow assurances from other Apple products.
Text findings
Conditions of use
Published controls and their limits
Subscription, cloud processing and privacy claims for this concept remain unverified. Do not borrow assurances from other Apple products.
What remains unknown?
Not tested or not established
Existence, availability and all product-specific control arrangements remain unresolved
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
Source-specific findings and retrieval limitations are recorded in the full report.
Earlier review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Existence, availability and all product-specific control arrangements remain unresolved No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Earlier review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
Not assessed · Low, no verified named deployment (AI-assisted draft)